A 52-year-old woman, with a metastatic breast cancer, presented with a nasal septum perforation while receiving a treatment combining paclitaxel and bevacizumab. This is the fifth reported case of nasal septum perforation probably related to an anti-angiogenic therapy. A literature review and a discussion concerning the different causes of nasal septum perforation were performed.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.revmed.2010.04.015 | DOI Listing |
Publication Analysis
Top Keywords
septum perforation
16
nasal septum
12
[nasal septum
4
perforation
4
perforation bevacizumab]
4
bevacizumab] 52-year-old
4
52-year-old woman
4
woman metastatic
4
metastatic breast
4
breast cancer
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!